⌘K

Home/Filings/4/0000899243-21-025410

4//SEC Filing

Lo Andrew 4

Accession 0000899243-21-025410

CIK 0001743881other

View on SEC.gov Company Profile

Filed

Jun 21, 8:00 PM ET

Accepted

Jun 22, 7:38 PM ET

Size

5.4 KB

Accession

0000899243-21-025410

Insider Transaction Report

Form 4

Period: 2021-06-17

BridgeBio Pharma, Inc.BBIO

Director

Transactions

Award
Stock Option (right to buy)
2021-06-17+38,895→ 38,895 total
Exercise: $62.63Exp: 2031-06-16→ Common Stock (38,895 underlying)

Footnotes (1)

[F1]The stock option vests and becomes exercisable in three annual installments after June 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

BridgeBio Pharma, Inc.

CIK 0001743881

Entity typeother

Related Parties

1

filerCIK 0001679076

Filing Metadata

Form type: 4
Filed: Jun 21, 8:00 PM ET
Accepted: Jun 22, 7:38 PM ET
Size: 5.4 KB

View on SEC.gov